Ajax-Loading

Takeda Pharmaceutical Co. Ltd. - Change Receivables

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Change-Receivables" stands at 46.90 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 09/30/2024.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 16.50 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 16.50 Billion Japanese Yens.
The 3 year change is -129.67 Billion Japanese Yens.
The 5 year change is 29.33 Billion Japanese Yens.
The 10 year change is 77.10 Billion Japanese Yens.

The Serie's long term average value is 0.924 Billion Japanese Yens. It's latest available value, on 09/30/2025, is 45.98 Billion Japanese Yens higher, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 09/30/2013, to it's latest available value, on 09/30/2025, is +121.31 Billion.
The Serie's change in Japanese Yens from it's maximum value, on 09/30/2022, to it's latest available value, on 09/30/2025, is -129.67 Billion.

Change Receivables for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Change Receivables905,699,262,464.00
LogoJohnson & Johnson - Change Receivables486,508,953,600.00
LogoAbbVie Inc - Change Receivables399,570,305,024.00
LogoRoche Holding AG - Change Receivables317,433,206,677.55
LogoAstraZeneca PLC - Change Receivables280,205,508,085.11